The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EFFECT-neo: A phase 3 study of pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy in patients with resectable locally advanced head and neck squamous cell carcinoma.
 
Yang Zhang
No Relationships to Disclose
 
Wei Guo
No Relationships to Disclose
 
Wenchao Zhang
No Relationships to Disclose
 
Zhenyu Wang
No Relationships to Disclose
 
Kai Yu
No Relationships to Disclose
 
Li Li
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Zhigang Huang
No Relationships to Disclose